Longevity Medicine
By Faisal Darwiche, NP — 2026-06-06
Everyone wants the number, and anyone who hands you one is guessing or selling. The honest answer is that a cash-pay hormone, TRT, or weight-loss clinic *can* be one of the higher-margin practices an NP can run — but the margin comes from a specific structure, not from the category itself. I run cash-pay services in my own practice, so let me walk through what actually drives the economics instead of a fantasy P&L.
It can be, and the reason is structural: these are cash-pay, recurring-revenue services with relatively contained per-patient cost. You remove insurance overhead, patients commit to ongoing programs, and your time converts directly to revenue. That combination is why the category attracts operators. But "can be profitable" isn't "is profitable" — margin depends on your pricing discipline, your patient retention, your medication and lab costs, and how lean you keep overhead. The model creates the *opportunity*; the operator decides whether it's realized.
*Income and profitability vary widely by market, model, pricing, and operator. Nothing here is a promise or projection of earnings.*
Four things, in roughly this order:
Get recurring revenue and pricing right and the rest is manageable. Get them wrong and no volume saves you.
The quiet killers: discounting to fill a schedule, high patient churn, overbuilt overhead before demand justifies it, and sloppy or gray-market sourcing that creates compliance risk (the most expensive line item of all — a shutdown). Weight-loss clinics in particular can chase volume with low prices and high churn and end up busy but unprofitable. A smaller panel of retained, properly priced members usually beats a churning crowd of discounted one-offs.
Because it changes the entire economics from "how many new patients did I close this month" to "how much does my existing panel generate before I do anything." A membership or program structure means revenue compounds as you retain patients, your marketing cost per dollar of revenue drops, and the practice becomes predictable enough to plan around. This is the core reason the cash-pay model fits longevity and weight-loss medicine — and why a clinic built on one-off visits leaves most of its potential on the table.
Build the model on paper before you build it in a lease. Estimate your real per-patient cost (medication, labs, your time), set a price that covers it with honest margin, and project off retained members, not optimistic new-patient counts. Then pressure-test it: what happens at half the patient volume you hope for? A model that only works at the optimistic number isn't a model — it's a wish. If it works at conservative retention, you've got a real practice. For the full build, start with how to start a GLP-1 weight-loss clinic.
There's no honest single number — it depends on your pricing, retention, costs, and market. The structure can support strong margins because it's cash-pay and recurring, but earnings vary widely by operator. Be skeptical of anyone quoting a guaranteed figure.
Recurring revenue from memberships or programs, pricing to value rather than discounting, legal and efficient medication sourcing, and disciplined overhead. The biggest lever is retained recurring revenue; the biggest killer is churn plus discounting.
Both can carry strong margins for the same structural reasons — cash-pay, recurring, contained per-patient cost. Hormone work often retains patients longer because optimization is ongoing. Actual margin depends on pricing and costs, not the category alone.
Yes — hormones, TRT, and GLP-1 medications all require prescribing, which means an NP, PA, or physician, and a collaborative agreement in reduced- or restricted-practice states. An RN can administer ordered injections but can't own the prescribing. Confirm with your board.
That depends on your fixed costs, pricing, and how fast you build a retained panel — there's no fixed timeline, and anyone promising one is guessing. Model it off conservative retention and you'll have a realistic picture for your own market.
The free 17-question assessment returns a state-specific 90-day launch plan: scope, entity, supplier sequence, and the exact next action for your scenario. 7 minutes. No card. Built by Faisal Darwiche, NP.
About the author
Faisal Darwiche, NP, is the founder of My Practice Academy. He's an AANP-certified nurse practitioner (MSN, adult-gerontology primary care) with 27+ years of clinical experience, a key opinion leader for leading aesthetic device companies, and faculty at The Aesthetic Show. He runs cash-pay longevity and wellness services in his own practices, has built and sold an aesthetics practice, and currently operates three. This article is general educational guidance, not legal, medical, or financial advice; confirm scope-of-practice, prescribing, and business requirements with your state board and your own counsel.